Johnstone EKM - Search Results

1

The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer.

Golden E, Rashwan R, Woodward EA, Sgro A, Wang E, Sorolla A, Waryah C, Tie WJ, Cuyàs E, Ratajska M, Kardaś I, Kozlowski P, Johnstone EKM, See HB, Duffy C, Parry J, Lagerborg KA, Czapiewski P, Menendez JA, Gorczyński A, Wasag B, Pfleger KDG, Curtis C, Lee BK, Kim J, Cursons J, Pavlos NJ, Biernat W, Jain M, Woo AJ, Redfern A, Blancafort P. Golden E, et al. Among authors: johnstone ekm. Nat Commun. 2021 Mar 26;12(1):1920. doi: 10.1038/s41467-021-22101-7. Nat Commun. 2021. PMID: 33772001 Free PMC article.

2

Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer.

Duffy C, Sorolla A, Wang E, Golden E, Woodward E, Davern K, Ho D, Johnstone E, Pfleger K, Redfern A, Iyer KS, Baer B, Blancafort P. Duffy C, et al. NPJ Precis Oncol. 2020 Sep 1;4:24. doi: 10.1038/s41698-020-00129-0. eCollection 2020. NPJ Precis Oncol. 2020. PMID: 32923684 Free PMC article.

3

[No title available]

[No authors listed] [No authors listed] PMID: 34465853

4

Bioluminescence Resonance Energy Transfer Approaches to Discover Bias in GPCR Signaling.

Johnstone EK, Pfleger KD. Johnstone EK, et al. Methods Mol Biol. 2015;1335:191-204. doi: 10.1007/978-1-4939-2914-6_13. Methods Mol Biol. 2015. PMID: 26260602

5

Complex interactions between the angiotensin II type 1 receptor, the epidermal growth factor receptor and TRIO-dependent signaling partners.

Johnstone EKM, Abhayawardana RS, See HB, Seeber RM, O'Brien SL, Thomas WG, Pfleger KDG. Johnstone EKM, et al. Biochem Pharmacol. 2021 Jun;188:114521. doi: 10.1016/j.bcp.2021.114521. Epub 2021 Mar 17. Biochem Pharmacol. 2021. PMID: 33741329

6

Profiling novel pharmacology of receptor complexes using Receptor-HIT.

Johnstone EKM, Pfleger KDG. Johnstone EKM, et al. Biochem Soc Trans. 2021 Aug 27;49(4):1555-1565. doi: 10.1042/BST20201110. Biochem Soc Trans. 2021. PMID: 34436548 Free PMC article. Review.

7

GPCR heteromers: An overview of their classification, function and physiological relevance.

Dale NC, Johnstone EKM, Pfleger KDG. Dale NC, et al. Among authors: johnstone ekm. Front Endocrinol (Lausanne). 2022 Aug 30;13:931573. doi: 10.3389/fendo.2022.931573. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36111299 Free PMC article. Review.

8

Receptor-Heteromer Investigation Technology and its application using BRET.

Johnstone EK, Pfleger KD. Johnstone EK, et al. Front Endocrinol (Lausanne). 2012 Aug 22;3:101. doi: 10.3389/fendo.2012.00101. eCollection 2012. Front Endocrinol (Lausanne). 2012. PMID: 22936924 Free PMC article.

9

Using nanoBRET and CRISPR/Cas9 to monitor proximity to a genome-edited protein in real-time.

White CW, Vanyai HK, See HB, Johnstone EKM, Pfleger KDG. White CW, et al. Among authors: johnstone ekm. Sci Rep. 2017 Jun 9;7(1):3187. doi: 10.1038/s41598-017-03486-2. Sci Rep. 2017. PMID: 28600500 Free PMC article.

10

NanoBRET ligand binding at a GPCR under endogenous promotion facilitated by CRISPR/Cas9 genome editing.

White CW, Johnstone EKM, See HB, Pfleger KDG. White CW, et al. Among authors: johnstone ekm. Cell Signal. 2019 Feb;54:27-34. doi: 10.1016/j.cellsig.2018.11.018. Epub 2018 Nov 22. Cell Signal. 2019. PMID: 30471466 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page